Apotheek Rotselaar-Heikant SRL
Apotheek Rotselaar-Heikant reported total assets of 323,195 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of Apotheek Rotselaar-Heikant shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Rotselaar-Heikant's annual accounts
| 2025 | |
|---|---|
| Net result | −61,184 € |
| Equity | −56,184 € |
| Cash | 8,316 € |
| EBITDA | −50,262 € |
| Total assets | 323,195 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
Apotheek Rotselaar-Heikant's financial analysis
- Solvency-17.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Rotselaar-Heikant
Apotheek Rotselaar-Heikant's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1012.043.263
- VAT number
- BE1012043263
- Peppol
- Registered · 0208:1012043263 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Jul 2024
- Registered office
- 3110 Rotselaar
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Rotselaar-Heikant (SRL) has been based in Rotselaar since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 61,184 € and equity of −56,184 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Rotselaar-Heikant
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Baudoux M.C. Retail sale of pharmaceutical products Gerpinnes · balance sheet 313,886 €
- Milan Apotica Retail sale of pharmaceutical products Waterloo · balance sheet 321,144 €
- Verapharm Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 327,020 €
- Vision 2017 Retail sale of pharmaceutical products Schaerbeek · balance sheet 318,760 €
- Medi Falcon Retail sale of pharmaceutical products Aalst · balance sheet 328,898 €
- Somapi Retail sale of pharmaceutical products Liège · balance sheet 317,064 €
- Geassocieerde Apotheek Ekeren Retail sale of pharmaceutical products Antwerp · balance sheet 331,202 €
- Pharma-Thuillies Retail sale of pharmaceutical products Thuin · balance sheet 400,573 €
Frequently asked questions about Apotheek Rotselaar-Heikant
What is the revenue of Apotheek Rotselaar-Heikant?
Apotheek Rotselaar-Heikant files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Rotselaar-Heikant?
In Belgium, the VAT number is the company number prefixed with BE: BE1012043263 for Apotheek Rotselaar-Heikant, if the company is VAT-registered. Its company number (CBE) is 1012.043.263.
Where is the registered office of Apotheek Rotselaar-Heikant?
According to the CBE register, the registered office of Apotheek Rotselaar-Heikant is in 3110 Rotselaar.
What is the equity of Apotheek Rotselaar-Heikant?
At the close of the 2025 financial year, the equity of Apotheek Rotselaar-Heikant amounts to -56,184 €, a solvency of -17.4% of total assets.
Who manages Apotheek Rotselaar-Heikant?
The register lists 2 active mandates at Apotheek Rotselaar-Heikant. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Rotselaar-Heikant
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →